Sheng-Wei Jin Selected Research

CD59 Antigens

1/2020	PCTR1 ameliorates lipopolysaccharide-induced acute inflammation and multiple organ damage via regulation of linoleic acid metabolism by promoting FADS1/FASDS2/ELOV2 expression and reducing PLA2 expression.
4/2018	Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheng-Wei Jin Research Topics

Disease

14	Inflammation (Inflammations) 01/2022 - 01/2013
10	Lung Injury 01/2022 - 01/2013
10	Acute Lung Injury 11/2021 - 02/2007
6	Pulmonary Edema 01/2022 - 02/2007
5	Sepsis (Septicemia) 01/2022 - 01/2018
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 04/2018
3	Edema (Dropsy) 04/2018 - 02/2007
1	Pneumonia (Pneumonitis) 07/2021
1	Necrosis 06/2021
1	Endotoxemia 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Gram-Negative Bacterial Infections 01/2020
1	Infections 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Ankylosing Spondylitis 01/2015
1	Hypoxia (Hypoxemia) 07/2014
1	Obstructive Sleep Apnea 07/2014

Drug/Important Bio-Agent (IBA)

16	LipopolysaccharidesIBA 11/2021 - 02/2007
6	LipidsIBA 01/2022 - 11/2015
5	Adenosine Triphosphatases (ATPase)IBA 11/2021 - 05/2013
5	lipoxin A4IBA 08/2019 - 02/2007
4	Epithelial Sodium ChannelsIBA 11/2021 - 05/2013
4	LipoxinsIBA 08/2019 - 01/2013
3	10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA 01/2022 - 01/2018
3	CytokinesIBA 07/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2007
2	Caspase 3 (Caspase-3)IBA 11/2021 - 08/2019
2	Docosahexaenoic AcidsIBA 11/2021 - 01/2017
2	Sirtuin 1IBA 07/2021 - 10/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 02/2007
2	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2013
2	Sodium Channels (Sodium Channel)IBA 01/2021 - 12/2020
2	CD59 AntigensIBA 01/2020 - 04/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2018 - 02/2007
1	Prostaglandin D2IBA 01/2022
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022
1	InterleukinsIBA 06/2021
1	ZymosanIBA 06/2021
1	Dexmedetomidine FDA Link 06/2021
1	Neutralizing AntibodiesIBA 06/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	AlbuminsIBA 01/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	Carbon MonoxideIBA 04/2018
1	Annexin A1IBA 04/2018
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 04/2018
1	Cyclic AMP (AMP, Cyclic)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 11/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Inositol (Myoinositol)IBA 07/2014
1	Phosphotransferases (Kinase)IBA 07/2014
1	EnzymesIBA 07/2014
1	Transcription Factor CHOPIBA 07/2014
1	salubrinalIBA 07/2014
1	resolvin D1IBA 04/2014
1	Oleic Acid (Oleate)IBA 05/2013
1	S 6 (S-6)IBA 05/2013
1	phenylalanylleucineIBA 05/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2007
1	Malondialdehyde (Propanedial)IBA 02/2007
1	Heme Oxygenase-1IBA 02/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2017
1	Ligation 01/2018
1	Punctures 01/2018